Advertisement
Expression of concern
Open Access | 10.1172/JCI198646
Find articles by Zhang, H. in: PubMed | Google Scholar
Find articles by He, Y. in: PubMed | Google Scholar
Find articles by Dai, S. in: PubMed | Google Scholar
Find articles by Xu, Z. in: PubMed | Google Scholar
Find articles by Luo, Y. in: PubMed | Google Scholar
Find articles by Wan, T. in: PubMed | Google Scholar
Find articles by Luo, D. in: PubMed | Google Scholar
Find articles by Jones, D. in: PubMed | Google Scholar
Find articles by Tang, S. in: PubMed | Google Scholar
Find articles by Chen, H. in: PubMed | Google Scholar
Find articles by Sessa, W. in: PubMed | Google Scholar
Find articles by Min, W. in: PubMed | Google Scholar
Published September 16, 2025 - More info
ASK1-interacting protein-1 (AIP1), a recently identified member of the Ras GTPase-activating protein family, is highly expressed in vascular ECs and regulates EC apoptosis in vitro. However, its function in vivo has not been established. To study this, we generated AIP1-deficient mice (KO mice). Although these mice showed no obvious defects in vascular development, they exhibited dramatically enhanced angiogenesis in 2 models of inflammatory angiogenesis. In one of these models, the enhanced angiogenesis observed in the KO mice was associated with increased VEGF-VEGFR2 signaling. Consistent with this, VEGF-induced ear, cornea, and retina neovascularization were greatly augmented in KO mice and the enhanced retinal angiogenesis was markedly diminished by overexpression of AIP1. In vitro, VEGF-induced EC migration was inhibited by AIP1 overexpression, whereas it was augmented by both AIP1 knockout and knockdown, with the enhanced EC migration caused by AIP1 knockdown being associated with increased VEGFR2 signaling. We present mechanistic data that suggest AIP1 is recruited to the VEGFR2-PI3K complex, binding to both VEGFR2 and PI3K p85, at a late phase of the VEGF response, and that this leads to inhibition of VEGFR2 signaling. Taken together, our data demonstrate that AIP1 functions as an endogenous inhibitor in VEGFR2-mediated adaptive angiogenesis in mice.
Haifeng Zhang, Yun He, Shengchuan Dai, Zhe Xu, Yan Luo, Ting Wan, Dianhong Luo, Dennis Jones, Shibo Tang, Hong Chen, William C. Sessa, Wang Min
Original citation: J Clin Invest. 2008;118(12):3904-3916. https://doi.org/10.1172/JCI36168
Citation for this expression of concern: J Clin Invest. 2025;135(18):e198646. https://doi.org/10.1172/JCI198646
The authors recently became aware of errors in the Western blot data presented in Figures 6A and 3F and Supplemental Figure 6B, which included duplicated blot images that were used to represent distinct samples. Given the time that has elapsed since publication, some of the primary data related to these figures is no longer available. As we are unable to evaluate the integrity of all of these figure panels, the Editors are publishing this notice to alert readers to the concern.